Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 330.14 Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded.
21 CFR 330.14 Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded., “Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not…”, is a CFR section of 21 CFR Part 330, Subpart B—Administrative Procedures; in force.
https://ontology.bommaritollc.com/id/01a0f094-c51f-71ff-a01e-42493ca9cf85
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 330.14 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbrandeden |
| schema:url | |
| skos:prefLabel | 21 CFR 330.14 Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded.en |
Related
Cited by (7)eli:cites
- 21 CFR 330.13 Conditions for marketing ingredients recommended for over-the-counter (OTC) use under the OTC drug review.
- 21 CFR 330.15 Timelines for FDA review and action on time and extent applications and safety and effectiveness data submissions.
- 21 U.S.C. 355h Regulation of certain nonprescription drugs that are marketed without an approved drug application
- 21 U.S.C. 360fff Definitions
- 21 U.S.C. 360fff-2 Eligibility determinations; data submission; filing
- 21 U.S.C. 360fff-3 GRASE determination
- 21 U.S.C. 360fff-6 Non-sunscreen time and extent applications